- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07751445
Unilateral and Bilateral Resistance Training in Hypertension
Comparison of the Effects of Unilateral and Bilateral Resistance Training on Heart Rate Variability, Muscle Strength, and Functional Capacity in Individuals With Hypertension: A Randomized Controlled Trial
Hypertension is associated with autonomic nervous system dysfunction, reduced muscle strength, and impaired functional capacity, all of which contribute to increased cardiovascular risk and decreased quality of life. Resistance training is recommended as a non-pharmacological intervention for hypertension; however, it remains unclear whether unilateral and bilateral resistance training produce different physiological adaptations, particularly regarding cardiac autonomic function.
This randomized controlled trial aims to compare the effects of unilateral and bilateral resistance training on heart rate variability (HRV), muscle strength, and functional capacity in adults with hypertension. Eligible participants aged 40-75 years with a confirmed diagnosis of hypertension will be randomly allocated to one of three groups: a unilateral resistance training group, a bilateral resistance training group, or a control group. Randomization will be performed using a computer-generated block randomization procedure with sex stratification to ensure balanced group allocation.
Participants in the two intervention groups will complete a supervised 12-week resistance training program, performed twice weekly at an intensity of 60-70% of one-repetition maximum (1RM). The unilateral training group will perform exercises using one limb at a time, whereas the bilateral training group will perform the same exercises simultaneously with both limbs. The control group will receive no structured exercise intervention during the study period but will receive general information regarding the benefits of physical activity.
Assessments will be conducted at baseline and after the 12-week intervention. The primary outcome will be heart rate variability measured using a Polar H10 heart rate sensor and Elite HRV software. Secondary outcomes will include peripheral muscle strength assessed by one-repetition maximum testing, functional capacity assessed using the Six-Minute Walk Test and the Glittre Activities of Daily Living Test, and blood pressure measured using a sphygmomanometer.
The findings of this study are expected to provide evidence regarding the optimal resistance training strategy for improving autonomic function and physical performance in individuals with hypertension, thereby supporting the development of safer and more individualized exercise prescriptions.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Hypertension is one of the leading modifiable risk factors for cardiovascular disease and is strongly associated with autonomic nervous system dysfunction. Increased sympathetic activity and reduced parasympathetic activity contribute to impaired cardiovascular regulation, which can be assessed non-invasively through heart rate variability (HRV). Reduced HRV has been associated with increased cardiovascular morbidity and mortality. In addition to autonomic dysfunction, individuals with hypertension frequently exhibit reduced muscle strength, impaired functional capacity, and limitations in daily physical activities.
Resistance training is widely recommended as a safe and effective non-pharmacological intervention for hypertension because it improves blood pressure control, muscular fitness, and overall physical function. Although both unilateral and bilateral resistance training are commonly prescribed, their physiological effects may differ. Unilateral resistance exercises generally involve a smaller active muscle mass, potentially resulting in lower cardiovascular stress while maintaining local muscular adaptations. In contrast, bilateral resistance exercises recruit a larger muscle mass and may induce greater cardiovascular and hemodynamic responses. Despite these theoretical differences, evidence directly comparing their effects on cardiac autonomic regulation in individuals with hypertension remains limited.
The primary objective of this randomized controlled trial is to compare the effects of unilateral and bilateral resistance training on cardiac autonomic function assessed by HRV in adults with hypertension. Secondary objectives include evaluating changes in peripheral muscle strength, functional capacity, activities of daily living, and blood pressure following a supervised resistance training program.
Adults aged 40 to 75 years with a physician-confirmed diagnosis of hypertension who are able to participate safely in resistance exercise will be recruited from Munzur University and Tunceli State Hospital. After providing written informed consent, eligible participants will be randomly assigned to one of three groups using a computer-generated block randomization procedure with sex stratification:
Unilateral Resistance Training Group Bilateral Resistance Training Group Control Group
Participants allocated to the intervention groups will complete a supervised 12-week resistance training program performed twice weekly. Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM). Both intervention groups will perform the same resistance exercises, including leg press, knee extension, leg curl, seated row, and chest press. The unilateral group will perform each exercise separately with the right and left limbs, whereas the bilateral group will perform the exercises simultaneously using both limbs. Each exercise session will consist of 2-3 sets of 8-12 repetitions with at least one minute of rest between sets. Training loads will be progressively increased when participants are able to perform more than 20 repetitions with a perceived exertion below 3 on the Modified Borg Scale.
Participants in the control group will not receive supervised resistance training during the 12-week intervention period but will receive standardized education regarding the health benefits of regular physical activity. Following study completion, participants in the control group will be offered the exercise intervention if the training program is demonstrated to be beneficial.
Outcome assessments will be performed at baseline and after completion of the 12-week intervention. HRV will be measured using a Polar H10 heart rate sensor connected to the Elite HRV application. Measurements will be obtained before exercise, immediately after exercise, and during the recovery period. Time-domain variables, including RMSSD, SDNN, pNN50, and mean RR interval, as well as frequency-domain variables, including total power, LF power, HF power, LF/HF ratio, LF peak frequency, and HF peak frequency, will be analyzed.
Peripheral muscle strength will be evaluated using one-repetition maximum testing for leg press, knee extension, leg curl, seated row, and chest press. Functional capacity will be assessed using the Six-Minute Walk Test (6MWT), while functional performance in activities of daily living will be evaluated using the Glittre Activities of Daily Living Test (Glittre-ADL). Resting and exercise blood pressure will be measured using a validated sphygmomanometer.
The study hypothesis is that unilateral resistance training will produce improvements in HRV, muscle strength, and functional capacity comparable to or greater than bilateral resistance training while imposing lower cardiovascular stress. The findings are expected to provide evidence supporting individualized resistance exercise prescription for individuals with hypertension and contribute to the optimization of exercise-based cardiovascular rehabilitation programs.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Ceyhun TOPCUOGLU, Dr.
- Número de teléfono: +90 535 653 51 37
- Correo electrónico: ceyhuntopcuoglu1@gmail.com
Ubicaciones de estudio
-
-
-
Tunceli, Turquía (Türkiye)
- Reclutamiento
- Munzur University Faculty of Health Sciences
-
Contacto:
- Ulku OZBEY, Prof. Dr.
- Número de teléfono: +90 531 435 88 94
- Correo electrónico: ulkuozbey@munzur.edu.tr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adults aged 40 to 75 years.
- Physician-confirmed diagnosis of hypertension.
- Medically stable and able to safely participate in a supervised resistance training program.
- Able to understand the study procedures and provide written informed consent.
Exclusion Criteria:
- Presence of cardiovascular diseases other than hypertension.
- Neurological disorders.
- Psychiatric disorders.
- Orthopedic conditions limiting participation in resistance exercise.
- Any other systemic disease that may interfere with study participation.
- Cognitive impairment or psychological conditions preventing completion of the assessments.
- History of recent surgery or medical conditions contraindicating exercise.
- Inability or unwillingness to comply with the study protocol.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Unilateral Resistance Training Group
Participants will receive a supervised unilateral resistance training program twice weekly for 12 weeks.
Training intensity will be set at 60-70% of one-repetition maximum (1RM).
Exercises will include leg press, knee extension, leg curl, seated row, and chest press, performed separately with the right and left limbs.
Each session will consist of 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets.
Training load will be progressively increased according to participants' performance and perceived exertion.
|
Participants will complete a supervised unilateral resistance training program twice weekly for 12 weeks.
Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM).
Exercises include leg press, knee extension, leg curl, seated row, and chest press performed separately with the right and left limbs.
Each session consists of 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets.
Training loads will be progressively increased based on participants' performance and perceived exertion using the Modified Borg Scale.
|
|
Experimental: Bilateral Resistance Training Group
Participants will receive a supervised bilateral resistance training program twice weekly for 12 weeks.
Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM).
The training program will include leg press, knee extension, leg curl, seated row, and chest press performed simultaneously with both limbs.
Each exercise will be completed for 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets.
Training intensity will be progressively increased according to participants' performance and perceived exertion.
|
Participants will complete a supervised bilateral resistance training program twice weekly for 12 weeks.
Exercise intensity will be prescribed at 60-70% of one-repetition maximum (1RM).
Exercises include leg press, knee extension, leg curl, seated row, and chest press performed simultaneously with both limbs.
Each session consists of 2-3 sets of 8-12 repetitions with at least 1 minute of rest between sets.
Training loads will be progressively increased according to participants' performance and perceived exertion using the Modified Borg Scale.
|
|
Sin intervención: Control Group
Participants assigned to the control group will not receive supervised resistance training during the 12-week study period.
They will receive standardized education regarding the health benefits of regular physical activity.
After study completion, participants will be offered the exercise program if the intervention is shown to be beneficial.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Muscle Strength
Periodo de tiempo: Baseline and Week 12
|
Muscle strength will be assessed using one-repetition maximum (1RM) testing for leg press, knee extension, leg curl, seated row, and chest press exercises.
|
Baseline and Week 12
|
|
Functional Capacity
Periodo de tiempo: Baseline and Week 12
|
Functional capacity will be evaluated using the Six-Minute Walk Test (6MWT).
Walking distance and physiological responses will be recorded before and after the intervention.
|
Baseline and Week 12
|
|
RMSSD
Periodo de tiempo: Baseline and Week 12
|
Change in the root mean square of successive differences (RMSSD) measured using heart rate variability analysis.
RMSSD is reported in milliseconds (ms).
Minimum value: 0 ms.
There is no fixed maximum value.
Higher values indicate greater parasympathetic activity and improved cardiac autonomic function (better outcome).
|
Baseline and Week 12
|
|
SDNN
Periodo de tiempo: Baseline and Week 12
|
Change in the standard deviation of normal-to-normal intervals (SDNN) measured using heart rate variability analysis.
SDNN is reported in milliseconds (ms).
Minimum value: 0 ms.
There is no fixed maximum value.
Higher values indicate greater overall heart rate variability and improved cardiac autonomic function (better outcome).
|
Baseline and Week 12
|
|
pNN50
Periodo de tiempo: Baseline and Week 12
|
Change in the percentage of successive normal-to-normal intervals differing by more than 50 ms (pNN50).
The outcome is expressed as a percentage (%).
Minimum value: 0%.
Maximum value: 100%.
Higher values indicate greater parasympathetic activity (better outcome).
|
Baseline and Week 12
|
|
Mean RR Interval
Periodo de tiempo: Baseline and Week 12
|
Change in mean RR interval measured using heart rate variability analysis.
The outcome is expressed in milliseconds (ms).
Minimum value: 0 ms.
There is no fixed maximum value.
Higher values generally indicate a lower resting heart rate and improved autonomic regulation (better outcome).
|
Baseline and Week 12
|
|
Total Power
Periodo de tiempo: Baseline and Week 12
|
Change in total power measured using heart rate variability analysis.
The outcome is expressed in milliseconds squared (ms²).
Minimum value: 0 ms².
There is no fixed maximum value.
Higher values indicate greater overall heart rate variability (better outcome).
|
Baseline and Week 12
|
|
LF Power
Periodo de tiempo: Baseline and Week 12
|
Change in low-frequency (LF) power measured using heart rate variability analysis.
The outcome is expressed in milliseconds squared (ms²).
Minimum value: 0 ms².
There is no fixed maximum value.
Higher values generally indicate greater autonomic modulation.
|
Baseline and Week 12
|
|
HF Power
Periodo de tiempo: Baseline and Week 12
|
Change in high-frequency (HF) power measured using heart rate variability analysis.
The outcome is expressed in milliseconds squared (ms²).
Minimum value: 0 ms².
There is no fixed maximum value.
Higher values indicate greater parasympathetic activity (better outcome).
|
Baseline and Week 12
|
|
LF Peak
Periodo de tiempo: Baseline and Week 12
|
Change in low-frequency peak (LF Peak) measured using heart rate variability analysis.
The outcome is expressed in hertz (Hz).
Minimum value: 0 Hz.
There is no fixed maximum value.
|
Baseline and Week 12
|
|
HF Peak
Periodo de tiempo: Baseline and Week 12
|
Change in high-frequency peak (HF Peak) measured using heart rate variability analysis.
The outcome is expressed in hertz (Hz).
Minimum value: 0 Hz.
There is no fixed maximum value.
|
Baseline and Week 12
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Activities of Daily Living
Periodo de tiempo: Baseline and Week 12
|
Change in activities of daily living performance assessed using the Glittre Activities of Daily Living (Glittre ADL) Test.
The outcome is the total time required to complete the Glittre ADL Test, measured in seconds (s).
Minimum value: 0 seconds.
There is no fixed maximum value.
Lower completion times indicate better functional performance in activities of daily living (better outcome), whereas higher completion times indicate poorer functional performance (worse outcome).
|
Baseline and Week 12
|
|
Blood Pressure
Periodo de tiempo: Baseline and Week 12
|
Systolic and diastolic blood pressure will be measured using a validated sphygmomanometer before exercise, immediately after exercise, and 30 minutes after exercise during the baseline and post-intervention assessments.
|
Baseline and Week 12
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2026/8-21
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .